As advancements in cell and gene therapy research continue to revolutionize the medical field, ensuring quality control in manufacturing processes is paramount to bringing life-saving treatments to market efficiently and safely.
While the potential benefits of these therapies are immense, challenges in maintaining quality standards pose significant risks to both drug developers and patients in need of innovative treatments.
